Company to show how materials science is helping pharmaceutical and consumer health companies protect sensitive therapies, bring care closer to the patient, and move beyond legacy materials September 29, 2026 09:50 ET | Source: TekniPlex Wayne, PA, Sept. 29, 2026 (GLOBE NEWSWIRE) — The materials that protect and deliver medicines are changing. Therapies are becoming
September 29, 2026 07:02 ET | Source: Boehringer Ingelheim Ingelheim, Germany, 28 September 2026 – Boehringer Ingelheim today announced that it projects its investments into sustainability-related programs and health partnerships that aim to help improve the lives of people, animals and their communities, for example by strengthening healthcare systems, projected to reach EUR 500 million
The consolidation of 26 businesses, acquired over six years, into one identity — now expressed through a new brand: PLG | Advanced Intelligence for Life Sciences September 29, 2026 07:00 ET | Source: ProductLife Group (PLG) PARIS, Sept. 29, 2026 (GLOBE NEWSWIRE) — ProductLife Group (PLG) today completes a multi-year transformation, uniting the 26 businesses
September 28, 2026 16:00 ET | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, and PARSIPPANY, N.J., Sept. 28, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved DEGEVMA™ (denosumab-adet) as a biosimilar to Xgeva® (denosumab). DEGEVMA is indicated for
Industry veteran brings more than two decades of oncology drug discovery leadership to advance Callio’s dual-payload ADC pipeline September 28, 2026 08:00 ET | Source: Callio Therapeutics SAN DIEGO and SEATTLE and SINGAPORE, Sept. 28, 2026 (GLOBE NEWSWIRE) — Callio Therapeutics (“Callio” or “the Company”), a global, clinical-stage biotechnology company advancing dual-payload antibody-drug conjugates (ADCs)
September 28, 2026 06:00 ET | Source: Zymeworks Inc. VANCOUVER, British Columbia, Sept. 28, 2026 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced the final transaction details and updated financial guidance following the completion of
Aiming to improve information sharing among medical staff and strengthen support systems for patients visiting from abroad September 25, 2026 07:00 ET | Source: Medical Corporation HELENE TOKYO, Sept. 25, 2026 (GLOBE NEWSWIRE) — Omotesando Helene Clinic (Japan) and Maison Privé Clinic (South Korea) have signed a Memorandum of Understanding (MOU) to promote medical exchange
September 24, 2026 16:00 ET | Source: Oil-Dri Corporation Of America CHICAGO, Sept. 24, 2026 (GLOBE NEWSWIRE) — Amlan® International, the animal health business of Oil-Dri® Corporation of America, will return to World Dairy Expo as the official Media Room sponsor. Taking place September 29–October 2 in Madison, Wisconsin, World Dairy Expo brings together dairy
September 24, 2026 08:00 ET | Source: Boehringer Ingelheim Ingelheim, Germany – Boehringer Ingelheim and the WHO Foundation today announced a three-year collaboration to accelerate progress on obesity and its related metabolic conditions in resource-limited settings. Obesity is one of the most pressing global health challenges. In 2022, more than 2.5 billion adults and over
Heidelberg site to lead GMP development of lactoperoxidase and glucose oxidase for Phase II clinical trials September 24, 2026 02:55 ET | Source: AGC Biologics, Inc. HEIDELBERG, Germany, Sept. 24, 2026 (GLOBE NEWSWIRE) — Belgian biopharmaceutical company Flen Health has selected AGC Biologics as their CDMO partner to provide process development, scale-up, and GMP manufacturing
September 23, 2026 16:45 ET | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q3 2026 Aide Memoire is available on the “Investors” page on its website. Q3 2026 Aide Memoire Teva has compiled
September 23, 2026 16:45 ET | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter 2026 financial results on Tuesday, November 3, 2026, at 7:00 a.m.
September 23, 2026 16:01 ET | Source: Zymeworks Inc. VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today completed the previously announced acquisition of Theravance Biopharma. With the completion of the
September 23, 2026 12:01 ET | Source: Smith & Nephew UK Ltd The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the EVOS PELVIC Plating System, the next evolution of the EVOS plating platform designed to
September 23, 2026 11:11 ET | Source: Smith & Nephew UK Ltd The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the EVOS PELVIC Plating System, the next evolution of the EVOS plating platform designed to address
